Preventing broken bones after menopause means addressing bone loss and falls, which cause most fractures. A 2026 review in Endocrine Reviews looked at bone health after menopause. It covered osteoporosis, a condition that makes bones weak and easier to break. This was a review of existing evidence, not one new experiment. Its main message: the chance of a broken bone matters most, not just changes in a bone reading. The review describes ongoing bone loss after menopause. It highlights balanced eating, safe physical activity, and not smoking. Severe vitamin D deficiency speeds up bone loss. Preventing falls becomes more important as people age. Medicines differ in how they protect bones and how long they work. Bisphosphonates slow the breakdown of bone. One drug in this group, zoledronate, is given through a vein. The review reports effects on bone renewal, density, and fractures beyond 10 years after one dose. Denosumab also prevents fractures, but its effects fade quickly after stopping. Some bone-building medicines are used for 1–2 years in people at high risk. Treatment then shifts to medicines that slow bone breakdown. The best order of treatments still needs more study. For this community, the type of measurement matters. Bone Mass is a smart-scale estimate of bone mineral. It can help track trends, but it is not Bone Mineral Density, measured with a bone density scan. A scale trend alone cannot show whether a treatment prevents fractures. Comparing notes here can include measurement type, dates, routines, and any falls. That keeps similar-looking numbers from being treated as the same thing. What have you noticed in your bone measurements or daily habits since menopause?